易世博

REC609-Recombinant Human Cytomegalovirus Vaccine

REC609-Recombinant Human Cytomegalovirus Vaccine

 

We are developing a recombinant human cytomegalovirus vaccine (i.e., REC609) with our technology platform,The project is currently in the preclinical research stage.

亚博体育 足球app 皇冠官网 皇冠体育app下载 世界杯投注平台